Quick Answer
Alzamend Neuro, Inc. reported Net Income of -$4.51 million for fiscal year 2025.
Alzamend Neuro, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$4.51M | +54.6% |
| 2024 | -$9.95M | +33.1% |
| 2023 | -$14.88M | -20.4% |
| 2022 | -$12.36M | -145.0% |
| 2021 | -$5.05M | -14.4% |
| 2020 | -$4.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | -$1.00M | +26.5% | +63.0% |
| July 31, 2025 | -$2.70M | -177.4% | -160.0% |
| January 31, 2025 | -$1.04M | +61.0% | +23.7% |
| October 31, 2024 | -$1.36M | +53.1% | -39.7% |
| July 31, 2024 | -$974.4K | +72.4% | +63.4% |
| January 31, 2024 | -$2.66M | +50.9% | +8.4% |
| October 31, 2023 | -$2.91M | +6.6% | +17.6% |
| July 31, 2023 | -$3.53M | -16.2% | +35.0% |
- Alzamend Neuro, Inc. showed an increase of +54.6% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Alzamend Neuro, Inc.’s net income has declined by 2.4% (from -$4.41 million to -$4.51 million).
- The most recent figure is from Alzamend Neuro, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 22, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: